申请人:Berger Jacob
公开号:US20100160384A1
公开(公告)日:2010-06-24
Compounds of the formula I:
or pharmaceutically acceptable salts thereof, wherein m, n, p, q, R
1
, R
2
, R
3
, R
4
, R
5
and R
6
are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with the P2X7 purinergic receptor.
化合物的公式I:或其药用盐,其中m、n、p、q、R1、R2、R3、R4、R5和R6如本文所定义。还公开了制备这些化合物的方法,并将这些化合物用于治疗与P2X7嘌呤受体相关的疾病。